β-casomorphins: Do They Have Physiological Significance?

  • Hansjörg Teschemacher
Chapter

Abstract

Milk represents an essential food for the newborn mammal. In addition to nutrients milk contains a variety of important materials, e.g. substances with immunological relevance1 and a considerable number of hormones whose physiological significance is not yet clearly understood.2

Keywords

Opioid Peptide Bovine Milk Milk Intake Nursing Female Opioid Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    L.A. Hanson, The mammary gland as an immunological organ, Immunol. Today 3: 168 (1982).CrossRefGoogle Scholar
  2. 2.
    O. Koldovsky, Hormones in milk, Life Sei. 26: 1833 (1980).CrossRefGoogle Scholar
  3. 3.
    V. Brantl and H. Teschemacher, Opioids in milk, Trends Pharmacol. Sei 4: 193 (1983).Google Scholar
  4. 4.
    V. Brantl and K. Neubert, Opioid peptides derived from food proteins, Trends Pharmacol. Sci. 7: 6 (1986).CrossRefGoogle Scholar
  5. 5.
    C. Zioudrou and W.A. Klee, Possible roles of peptides derived from food proteins in brain functions, in: “Nutrition and the Brain”, R.J. Wurtman and J.J. Wurtman, eds., Raven Press, New York (1979).Google Scholar
  6. 6.
    S. Loukas, D. Varoucha, C. Zioudrou, R.A. Streaty and W.A. Klee, Opioid activities and structures of α-caseinderived exorphins, Biochemistry 22:4567 (1983).CrossRefGoogle Scholar
  7. 7.
    V. Brantl, H. Teschemacher, A. Henschen and F. Lottspeich, Novel opioid peptides derived from casein (ß-casomorphins): I. Isolation from bovine casein peptone, Hoppe-Seyler’s Z. Physiol. Chem. 360:1211 (1979).CrossRefGoogle Scholar
  8. 8.
    V. Brantl, Novel opioid peptides derived from human ß-casein: human ß-casomorphins, Eur. J. Pharmacol. 106:213 (1984).CrossRefGoogle Scholar
  9. 9.
    I.S. Zagon, P.J. McLaughlin, D.J. Weaver and E. Zagon, Opiates, endorphins and the developing organism: A comprehensive bibliography, Neurosci. Biobehav. Rev. 6:439 (1982).CrossRefGoogle Scholar
  10. 10.
    B. Ribadeau-Dumas, G. Brignon, F. Grosclaude and J.-C. Mercier, Structure primaire de la caseine ß-bovine: Sequence complete, Eur. J. Biochem. 25:505 (1972).CrossRefGoogle Scholar
  11. 11.
    A. Henschen, F. Lottspeich, V. Brantl and H. Teschemacher, Novel opioid peptides derived from casein (ß-casomorphins). II. Structure of active components from bovine casein peptone, Hoppe-Seyler’s Z. Physiol. Chem. 360:1216 (1979).Google Scholar
  12. 12.
    F. Lottspeich, A. Henschen, V. Brantl and H. Teschemacher, Novel opioid peptides derived from casein (ß-casomorphins). III. Synthetic peptides corresponding to components from bovine casein peptone, Hoppe-Seyler’s Z. Physiol. Chem. 361:1835 (1980).CrossRefGoogle Scholar
  13. 13.
    V. Brantl, H. Teschemacher, J. Bläsig, A. Henschen and F. Lottspeich, Opioid activities of ß-casomorphins, Life Sci. 28:1903 (1981).CrossRefGoogle Scholar
  14. 14.
    K.-J. Chang, P. Cuatrecasas, E.T. Wei and J.-K. Chang, Analgesic activity of intracerebroventicular administration of morphiceptin and ß-casomorphins: Correlation with the morphine (μ) receptor binding affinity, Life Sci, 30:1547 (1982).CrossRefGoogle Scholar
  15. 15.
    B.C. Richardson and J.C. Mercier, The primary structure of the ovine ß-caseins, Eur. J. Biochem. 99:285 (1979).CrossRefGoogle Scholar
  16. 16.
    P. Petrilli, F. Addeo and L. Chianese, Primary structure of water buffalo ß-casein: Tryptic and CNBr peptides, Ital. J. Biochem. 32:336 (1983).Google Scholar
  17. 17.
    R. Greenberg, M.L. Groves and H.J. Dower, Human ß-casein. Amino acid sequence and identification of phosphorylation sites, J. Biol. Chem. 259:5132 (1984).Google Scholar
  18. 18.
    G. Koch, K. Wiedemann and H. Teschemacher, Opioid activities of human ß-casomorphins, Naunyn-Schmiedeberg’s Arch. Pharmacol. 331:351 (1985).CrossRefGoogle Scholar
  19. 19.
    M. Yoshikawa, T. Yoshimura and H. Chiba, Opioid peptides from human ß-casein, Agric. Biol. Chem. 48:3185 (1984).CrossRefGoogle Scholar
  20. 20.
    W. Kromer, W. Pretzlaff and R. Woinoff, Regional Distribution of an opioid mechanism in the guinea-pig isolated intestine, J. Pharm. Pharmacol. 33:98 (1981).CrossRefGoogle Scholar
  21. 21.
    G. Grecksch, C. Schweigert and H. Matthies, Evidence for analgesic activity of ß-casomorphin in rats, Neurosci. Lett. 27:325 (1981).CrossRefGoogle Scholar
  22. 22.
    K.G. Reymann, A.N. Chepkova, K. Schulzeck and T. Ott, Effects of ß-casomorphin on dentate hippocampal field potentials in freely moving rats, Biomed. Biochim. Acta 44:749 (1985).Google Scholar
  23. 23.
    V. Schusdziarra, A. Holland, R. Schick, A. de la Fuente, M. Klier, V. Maier, V. Brantl and E.F. Pfeiffer, Modulation of post-prandial insulin release by ingested opiate-like substances in dogs, Diabetologia 24:113 (1983).CrossRefGoogle Scholar
  24. 24.
    V. Schusdziarra, R. Schick, A. de la Fuente, A. Holland, V. Brantl and E.F. Pfeiffer, Effect of ß-casomorphins on somatostatin release in dogs, Endocrinologyy 112:1948 (1983).CrossRefGoogle Scholar
  25. 25.
    V. Schusdziarra, R. Schick, A. Holland, A. de la Fuente, J. Specht, V. Maier, V. Brantl and E.F. Pfeiffer, Effect of opiate-active substances on pancreatic polypeptide levels in dogs, Peptides 4:205 (1983).CrossRefGoogle Scholar
  26. 26.
    T. Mitsuma, T. Nogimori and M. Chaya, ß-Casomorphin inhibits thyrotropin secretion in rats, Exp. Clin. Endocrinol. 84:324 (1984).CrossRefGoogle Scholar
  27. 27.
    J. Nedvidkova, E. Kasafirek, A. Dlabac and V. Felt, Effect of beta-casomorphin and its analogue on serum prolactin in the rat, Exp. Clin. Endocrinol. 85:249 (1985).CrossRefGoogle Scholar
  28. 28.
    J.E. Zadina and A.J. Kastin, Interactions between the antiopiate Tyr-MIF-1 and the Mu opiate morphiceptin at their respective binding sites in brain, Peptides 6:965 (1985).CrossRefGoogle Scholar
  29. 29.
    F. Parker, D. Migliore-Samour, F. Floch, A. Zerial, G.H. Werner, J. Jolies, M. Casaretto, H. Zahn and P. Jolies, Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties, Eur. J. Biochem. 145:677 (1984).CrossRefGoogle Scholar
  30. 30.
    P. Petrilli, D. Picone, C. Caporale, F. Addeo, S. Auricchio and G. Marino, Does casomorphin have a functional role? FEBS Lett. 169:53 (1984).CrossRefGoogle Scholar
  31. 31.
    J. Svedberg, J. de Haas, G. Leimenstoll, F. Paul and H. Teschemacher, Demonstration of ß-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans, Peptides 6:825 (1985).CrossRefGoogle Scholar
  32. 32.
    K.-J. Chang, Y.F. Su, D.A. Brent and J.-K. Chang, Isolation of a specific u-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins, J. Biol. Chem. 260:9706 (1985).Google Scholar
  33. 33.
    B. Hartrodt, K. Neubert, G. Fischer, U. Demuth, T. Yoshimoto and A. Barth, Degradation of ß-casomorphin-5 by proline-specific endopeptidase (PSE) and post-proline cleaving enzyme (PPCE), Pharmazie 37:72 (1982).Google Scholar
  34. 34.
    B. Hartrodt, K. Neubert, G. Fischer, H. Schulz and A. Barth, Synthese und enzymatischer Abbau von ß-Casomorphin-5, Pharmazie 37:165 (1982).Google Scholar
  35. 35.
    G. Kreil, M. Umbach, V. Brantl and H. Teschemacher, Studies on the enzymatic degradation of ß-casomorphins, Life Sci. 33, Suppl. 1:137 (1983).CrossRefGoogle Scholar
  36. 36.
    M. Umbach, H. Teschemacher, K. Praetorius, R. Hirschhäuser and H, Bostedt, Demonstration of a ß-casomorphin immurioreactive material in the plasma of newborn calves after milk intake, Reg. Peptides 12:223 (1985).CrossRefGoogle Scholar
  37. 37.
    G. Koch, K. Wiedemann and W. Zimmermann, Human β-Casomorphin-8 Immunoreactive materials in the plasma of nursing mothers, Naunyn-Schmiedeberg’s Arch. Pharmacol. 332:R 85 (1986).Google Scholar
  38. 38.
    H. Stark, B. Lössner and H. Matthies, Degradation of ß-casomorphin in the rat brain in vivo, Biomed. Biochim. Acta 45:557 (1986).Google Scholar
  39. 39.
    H. Meisel, Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein, FEBS Lett. 196:223 (1986).CrossRefGoogle Scholar
  40. 40.
    J.E. Morley, Food peptides: A new class of hormones? J. Am. Med. Assoc. 247:2379 (1982).CrossRefGoogle Scholar
  41. 41.
    H. Teschemacher, M. Umbach, U. Hamel, K. Praetorius, G. Ahnert-Hilger, V. Brantl, F. Lottspeich and A. Henschen, No evidence for the presence of ß-casomor-phins in human plasma after ingestion of cows’ milk or milk products, J. Dairy Res. 53:135 (1986).CrossRefGoogle Scholar
  42. 42.
    J. Panksepp, L. Normanseil, S. Siviy, J. Rossi III and A.J. Zolovick, Casomorphins reduce separation distress in chicks, Peptides 5:829 (1984).CrossRefGoogle Scholar
  43. 43.
    A. Ermisch, H.-J. Rühle, K. Neubert, B. Hartrodt and R. Landgraf, On the blood-brain barrier to peptides: H ß-casomorphin-5 uptake by eighteen brain regions in vivo, J. Neurochem. 41:1229 (1983).CrossRefGoogle Scholar
  44. 44.
    G. Püschel, R. Mentlein and E. Heymann, Isolation and characterization of dipeptidyl peptidase IV from human placenta, Eur. J. Biochem. 126:359 (1982).CrossRefGoogle Scholar
  45. 45.
    S.S.C. Yen, M.E. Quigley, R.L. Reid, J.F. Ropert and N.S. Cetel, Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion, Am. J. Obstet. Gynecol. 152:485 (1985).Google Scholar
  46. 46.
    C.A. Leadem and S.P. Kalra, Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats, Neuroendocrinology 41:342 (1985).CrossRefGoogle Scholar
  47. 47.
    D.M. Wright, Evidence for a spinal site at which opioids may act to inhibit the milk-ejection reflex, J. Endocrinol. 106:401 (1985).CrossRefGoogle Scholar
  48. 48.
    L.H. Lindström, F. Nyberg, L. Terenius, K. Bauer, G. Besev, L.M. Gunne, S. Lyrenäs, G. Willdeck-Lund and B. Lindberg, CSF and plasma ß-casomorphin-like opioid peptides in post-partum psychosis, Am. J. Psychiatry 141:1059 (1984).Google Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Hansjörg Teschemacher
    • 1
  1. 1.Rudolf Buchheim-Institut für PharmakologieJustus Liebig-UniversitätGießenGermany

Personalised recommendations